Amerant Bancorp (AMTB) Stock Faces Rich P/E As Net Margin Jumps To 14.4%

Amerant Bancorp (AMTB) opened Q2 2026 with total revenue of US$96.0 million and basic EPS of US$0.54, alongside trailing twelve month revenue of US$391.4 million and EPS of US$1.39. Reported earnings over the past year grew by 1,433.1% and revenue growth was 5.1% annually. The company has seen quarterly revenue move between US$87.0 million and US$108.7 million and basic EPS range from US$0.07 to US$0.55 over the past five reported periods. These figures may prompt investors to focus on how the latest margin profile and earnings volatility relate to the company’s profitability and risk.

See our full analysis for Amerant Bancorp.

With the headline results on the table, the next step is to see how these numbers line up against the key narratives around Amerant Bancorp, from earnings momentum to credit risk and everything in between.

See what the community is saying about Amerant Bancorp

Net margin at 14.4% puts profits back in focus

• The trailing net profit margin stands at 14.4%, compared with 1.2% a year ago, while trailing twelve month net income is US$56.4 million on revenue of US$391.4 million.
• Consensus narrative points to improved net interest margin and cost control supporting Amerant Bancorp, yet the data shows the cost to income ratio sitting in a tight band between 67.5% and 69.8% over the past five reported periods. This suggests that any further margin lift will likely depend on how efficiently those US$95.99 million to US$108.67 million quarterly revenue figures are converted into profit rather than on expense cuts alone.
  • For example, Q2 2026 net income of US$21.0 million on US$96.0 million of revenue contrasts with Q4 2025 net income of US$2.7 million on US$108.7 million of revenue, so recent profit levels are less about revenue size and more about profitability on each dollar of revenue.
  • That helps explain why trailing EPS of US$1.39 and the very large 1,433.1% earnings growth rate over the past year sit alongside only 5.1% annual revenue growth, which is slower than the broader US market revenue growth used in the analysis.

For a closer look at how different investors interpret these profit trends and where they think the story goes next, check out the See what the community is saying about Amerant Bancorp.

Credit quality: 2.7% bad loans keeps risk on the table

• Non performing loans are 2.7% of the book with an allowance covering 45% of those loans, and over the past five reported quarters non performing loans ranged from US$82.5 million to US$176.1 million while total loans sat between US$6.6 billion and US$7.2 billion.
• Bears highlight rising provisions and pressure in commercial loans, and the numbers support some of that concern because non performing loans increased from US$82.5 million in Q2 2025 to US$176.1 million by Q1 2026. If those problem loans translate into higher credit costs, the current 14.4% net margin and US$21.0 million Q2 2026 net income could be harder to maintain.
  • The analysis also flags that the 45% allowance coverage on bad loans is characterised as low, which means losses on the existing 2.7% bad loan pool could eat into future profits if actual losses run higher than the allowance.
  • Given that total loans moved from US$7.2 billion in Q2 2025 to US$6.6 billion by Q1 2026, critics argue that Amerant Bancorp is balancing growth ambitions with an asset quality profile that already carries elevated non performing exposure.

Skeptical investors who focus on those rising problem loans often drill into the more cautious side of the story, including how much earnings room there is if credit costs step up further. 🐻 Amerant Bancorp Bear Case

Premium 19.8x P/E leans on strong earnings swing

• Amerant Bancorp trades on a trailing P/E of 19.8x versus a peer average of 12.9x and a US Banks industry average of 12.1x, while trailing EPS is US$1.39 and the current share price is US$28.50.
• Bullish investors argue that the very large 1,433.1% earnings growth over the past year and forecast 28.7% annual earnings growth justify that premium, yet the same analysis shows revenue growth at 5.1% per year and a consensus analyst price target of US$25.75, which is below the current US$28.50 share price. There is a clear tension between strong profit momentum and the relatively modest revenue and price target expectations.
  • Supporters often point to expansion in Florida and stronger loan production as long term drivers, but the financials show trailing twelve month revenue essentially flat around US$388.5 million to US$399.6 million in recent periods rather than on a steep climb.
  • At the same time, the analyst scenario underpinning the US$25.75 target assumes earnings of US$105.0 million by about June 2029, so readers can compare that to today’s US$56.4 million trailing net income and decide whether paying a 19.8x P/E for that path fits their own expectations.

Supporters who want to see how optimistic investors connect this valuation premium back to the long term story often zoom in on the more upbeat narrative around earnings and loan growth. 🐂 Amerant Bancorp Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Amerant Bancorp on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mix of optimism and caution around Amerant Bancorp, it makes sense to review the underlying figures yourself and move quickly while sentiment is still split. To see how the current upside potential and downside risk balance out based on the latest data, take a closer look at the 2 key rewards and 2 important warning signs.

See What Else Is Out There

Amerant Bancorp combines a premium 19.8x P/E and rising bad loans at 2.7% of the book with relatively flat revenue and a low 45% allowance coverage.

If you are uneasy about that credit profile and want a sturdier foundation for your portfolio, check out solid balance sheet and fundamentals stocks screener (49 results) to quickly focus on companies with stronger financial buffers.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com